Matrix-assisted laser desorption ionization/time-of-flight mass spectrometry for clinical diagnosis

Clinica Chimica Acta

Volumn 415, Issue , 2013, Pages 266-275

  Cho, Yi Tzu ^a   Su, Hung ^b   Huang, Tiao Lai ^c   Chen, Hung Chun ^d   Wu, Wen Jeng ^d   Wu, Pei Chang ^c   Wu, Deng Chyang ^e   Shiea, Jentaie ^b,d  

^a Yuh Ing Junior College of Health Care and Management   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Clinical diagnosis; Disease biomarkers; Matrix assisted laser desorption ionization time of flight mass spectrometry; Multivariate analysis; Principle component analysis

Indexed keywords

ALBUMIN; ALPHA DEFENSIN; BIOLOGICAL MARKER; GLYCATED ALPHA GLOBIN; GLYCATED BETA GLOBIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; PHOSPHOLIPID; TRIMETHYLAMINE; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG;

ABNORMAL URINE COMPOSITION; AGING; ALBUMINURIA; BRAIN ISCHEMIA; BREAST CANCER; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISEASE MARKER; DRY EYE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; HYDROLYSIS; LIMIT OF DETECTION; LIPID ANALYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIAL IDENTIFICATION; MOUTH CANCER; MULTIVARIATE ANALYSIS; OCCULT BLOOD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE DISTRIBUTION; TRIMETHYLAMINURIA;

AGING; ALBUMINURIA; BIOLOGICAL MARKERS; BREAST NEOPLASMS; DRY EYE SYNDROMES; FECES; FEMALE; HUMANS; LIPIDS; OCCULT BLOOD; PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STROKE; TISSUE EXTRACTS;

EID: 84870374901     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.10.032     Document Type: Review

References (93)

1. Hillenkamp F., Karas M. Mass spectrometry of peptides and proteins by matrix-assisted ultraviolet laser desorption/ionization. Methods Enzymol 1990, 193:280-295.
2. Nelson R.W., Dogruel D., Williams P. Mass determination of human immunoglobulin IgM using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 1994, 8:627-631.
3. Cramer R., Gobom J., Nordhoff E. High-throughput proteomics using matrix-assisted laser desorption/ionization mass spectrometry. Expert Rev Proteomics 2005, 2:407-420.
4. Kaufmann R. Matrix-assisted laser desorption ionization (MALDI) mass spectrometry: a novel analytical tool in molecular biology and biotechnology. J Biotechnol 1995, 41:155-175.
5. Stuhler K., Meyer H.E. MALDI: more than peptide mass fingerprints. Curr Opin Mol Ther 2004, 6:239-248.
6. Fenselau C. MALDI MS and strategies for protein analysis. Anal Chem 1997, 69:661A-665A.
7. Bonk T., Humeny A. MALDI-TOF-MS analysis of protein and DNA. Neuroscientist 2001, 7:6-12.
8. Wang H., Zhao Z., Guo Y. Chemical and biochemical applications of MALDI TOF-MS based on analyzing the small organic compounds. Top Curr Chem 2012, 96:1-28.
9. Harvey D.J. Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2007-2008. Mass Spectrom Rev 2012, 31:183-311.
10. Pusch W., Flocco M.T., Leung S.M., Thiele H., Kostrzewa M. Mass spectrometry-based clinical proteomics. Pharmacogenomics 2003, 4:463-476.
11. Parker C.E., Pearson T.W., Anderson N.L., Borchers C.H. Mass-spectrometry-based clinical proteomics-a review and prospective. Analyst 2010, 135:1830-1838.
12. Hendriks M.M., Smit S., Akkermans W.L., et al. How to distinguish healthy from diseased? Classification strategy for mass spectrometry-based clinical proteomics. Proteomics 2007, 7:3672-3680.
13. Iwadate Y. Clinical proteomics in cancer research-promises and limitations of current two-dimensional gel electrophoresis. Curr Med Chem 2008, 15:2393-2400.
14. Pusch W., Kostrzewa M. Application of MALDI-TOF mass spectrometry in screening and diagnostic research. Curr Pharm Des 2005, 11:2577-2591.
15. Marvin L.F., Roberts M.A., Fay L.B. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry. Clin Chim Acta 2003, 337:11-21.
16. Goodwin R.J., Pennington S.R., Pitt A.R. Protein and peptides in pictures: imaging with MALDI mass spectrometry. Proteomics 2008, 8:3785-3800.
17. Li L., Sweedler J.V. Peptides in the brain: mass spectrometry-based measurement approaches and challenges. Annu Rev Anal Chem (Palo Alto, Calif) 2008, 1:451-483.
18. Schwamborn K., Caprioli R.M. MALDI imaging mass spectrometry-painting molecular pictures. Mol Oncol 2010, 4:529-538.
19. Balluff B., Schone C., Hofler H., Walch A. MALDI imaging mass spectrometry for direct tissue analysis: technological advancements and recent applications. Histochem Cell Biol 2011, 136:227-244.
20. Seeley E.H., Caprioli R.M. MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives. Trends Biotechnol 2011, 29:136-143.
21. Croxatto A., Prod'hom G., Greub G. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev 2012, 36:380-407.
22. Lay J.O. MALDI-TOF mass spectrometry of bacteria. Mass Spectrom Rev 2001, 20:172-194.
23. Fenselau C., Demirev P.A. Characterization of intact microorganisms by MALDI mass spectrometry. Mass Spectrom Rev 2001, 20:157-171.
24. Ferreira L., Sanchez-Juanes F., Gonzalez-Avila M., et al. Direct identification of urinary tract pathogens from urine samples by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2010, 48:2110-2115.
25. Griffin T.J., Smith L.M. Single-nucleotide polymorphism analysis by MALDI-TOF mass spectrometry. Trends Biotechnol 2000, 18:77-84.
26. Pusch W., Wurmbach J.H., Thiele H., Kostrzewa M. MALDI-TOF mass spectrometry-based SNP genotyping. Pharmacogenomics 2002, 3:537-548.
27. Gut I.G. DNA analysis by MALDI-TOF mass spectrometry. Hum Mutat 2004, 23:437-441.
28. Ragoussis J., Elvidge G.P., Kaur K., Colella S. Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry in genomics research. PLoS Genet 2006, 2:e100.
29. Liu J.C., Chen W.J., Li C.W., et al. Identification of Pseudomonas aeruginosa using functional magnetic nanoparticle-based affinity capture combined with MALDI MS analysis. Analyst 2009, 134:2087-2094.
30. Kailasa S.K., Wu H.F. Functionalized quantum dots with dopamine dithiocarbamate as the matrix for the quantification of efavirenz in human plasma and as affinity probes for rapid identification of microwave tryptic digested proteins in MALDI-TOF-MS. J Proteomics 2012, 75:2924-2933.
31. Neubert H., Jacoby E.S., Bansal S.S., Iles R.K., Cowan D.A., Kicman A.T. Enhanced affinity capture MALDI-TOF MS: orientation of an immunoglobulin G using recombinant protein G. Anal Chem 2002, 74:3677-3683.
32. Cohen M., Yossef R., Erez T., et al. Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays. PLoS One 2011, 6:e14540.
33. Sparbier K., Wenzel T., Dihazi H., et al. Immuno-MALDI-TOF MS: new perspectives for clinical applications of mass spectrometry. Proteomics 2009, 9:1442-1450.
34. Wright G.L. SELDI proteinchip MS: a platform for biomarker discovery and cancer diagnosis. Expert Rev Mol Diagn 2002, 2:549-563.
35. Diamandis E.P. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics 2004, 3:367-378.
36. Tang N., Tornatore P., Weinberger S.R. Current developments in SELDI affinity technology. Mass Spectrom Rev 2004, 23:34-44.
37. Engwegen J.Y., Gast M.C., Schellens J.H., Beijnen J.H. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci 2006, 27:251-259.
38. Kiehntopf M., Siegmund R., Deufel T. Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations. Clin Chem Lab Med 2007, 45:1435-1449.
39. Castagna A., Campostrini N., Zaninotto F., Girelli D. Hepcidin assay in serum by SELDI-TOF-MS and other approaches. J Proteomics 2010, 73:527-536.
40. Aresta A., Calvano C.D., Palmisano F., et al. Impact of sample preparation in peptide/protein profiling in human serum by MALDI-TOF mass spectrometry. J Pharm Biomed Anal 2008, 46:157-164.
41. Shiea J., Cho Y.T., Lin Y.H., et al. Using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to rapidly screen for albuminuria. Rapid Commun Mass Spectrom 2008, 22:3754-3760.
42. Cho Y.T., Chen Y.S., Hu J.L., et al. The study of interferences for diagnosing albuminuria by matrix-assisted laser desorption ionization/time-of-flight mass spectrometry. Clin Chim Acta 2012, 413:875-882.
43. Simerville J.A., Maxted W.C., Pahira J.J. Urinalysis: a comprehensive review. Am Fam Physician 2005, 71:1153-1162.
44. Lin S.Y., Shih S.H., Wu D.C., et al. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for the detection of hemoglobins as the protein biomarkers for fecal occult blood. Rapid Commun Mass Spectrom 2007, 21:3311-3316.
45. Wu C.I., Tsai C.C., Lu C.C., et al. Diagnosis of occult blood in human feces using matrix-assisted laser desorption ionization/time-of-flight mass spectrometry. Clin Chim Acta 2007, 384:86-92.
46. Scholl PF, Demirev P, Feldman, AB. Occult blood detection in biological samples by laser desorption and matrix-assisted laser desorption/ionization mass spectrometry for biomedical applications. United states patent 2006; Patent No.: US7109038 B2.
47. Huang P., Lo L.H., Chen Y.C., Lin R.T., Shiea J., Liu C.K. Serum free hemoglobin as a novel potential biomarker for acute ischemic stroke. J Neurol 2009, 256:625-631.
48. Watanabe J., Chou K.J., Liao J.C., et al. Differential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic/hyperlipidemic mice. A novel biomarker of atherosclerosis. J Biol Chem 2007, 282:23698-23707.
49. Lezcano N.E., Odo N., Kutlar A., Brambilla D., Adams R.J. Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke. Stroke 2006, 37:1424-1426.
50. Buttari B., Profumo E., Petrone L., et al. Free hemoglobin: a dangerous signal for the immune system in patients with carotid atherosclerosis?. Ann N Y Acad Sci 2007, 1107:42-50.
51. Rother R.P., Bell L., Hillmen P., Gladwin M.T. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005, 293:1653-1662.
52. Na N., Ouyang J., Taes Y.E., Delanghe J.R. Serum free hemoglobin concentrations in healthy individuals are related to haptoglobin type. Clin Chem 2005, 51:1754-1755.
53. Lapolla A., Fedele D., Aronica R., et al. The in vivo glyco-oxidation of alpha- and beta-globins investigated by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 1996, 10:1133-1135.
54. Lapolla A., Fedele D., Aronica R., et al. Evaluation of IgG glycation levels by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 1997, 11:1342-1346.
55. Resemann A., Mayer-Posner F.J., Lapolla A., Fedele D., DA M., Traldi P. Further considerations on the use of matrix-assisted laser desorption/ionization mass spectrometry in the analysis of glycated globins. Rapid Commun Mass Spectrom 1998, 12:805-807.
56. Lapolla A., Fedele D., Plebani M., et al. Evaluation of glycated globins by matrix-assisted laser desorption/ionization mass spectrometry. Clin Chem 1999, 45:288-290.
57. Lapolla A., Fedele D., Plebani M., et al. Direct evaluation of glycated and glyco-oxidized globins by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 1999, 13:8-14.
58. Lapolla A., Fedele D., Garbeglio M., et al. Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and molecular modeling in the study of nonenzymatic glycation of IgG. J Am Soc Mass Spectrom 2000, 11:153-159.
59. Lapolla A., Tubaro M., Reitano R., et al. The complexity of non-enzymatic glycation product sets of human globins. Diabetologia 2004, 47:1712-1715.
60. Lapolla A., Tubaro M., Fedele D., et al. A matrix-assisted laser desorption/ionization mass spectrometry study of the non-enzymatic glycation products of human globins in diabetes. Rapid Commun Mass Spectrom 2005, 19:162-168.
61. Lapolla A., Ragazzi E., Andretta B., et al. Multivariate analysis of matrix-assisted laser desorption/ionization mass spectrometric data related to glycoxidation products of human globins in nephropathic patients. J Am Soc Mass Spectrom 2007, 18:1018-1023.
62. Lo L.H., Wu P.C., Wu Y.C., Shiea J. Characterization of human neutrophil peptides (α-Defensins) in the tears of dry eye patients. Anal Methods 2010, 2:1934-1940.
63. Munro N.P., Cairns D.A., Clarke P., et al. Urinary biomarker profiling in transitional cell carcinoma. Int J Cancer 2006, 119:2642-2650.
64. Hancock R.E., Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 2000, 8:402-410.
65. Tao R., Jurevic R.J., Coulton K.K., et al. Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob Agents Chemother 2005, 49:3883-3888.
66. Zhou L., Beuerman R.W., Huang L., et al. Proteomic analysis of rabbit tear fluid: defensin levels after an experimental corneal wound are correlated to wound closure. Proteomics 2007, 7:3194-3206.
67. Yang M.H., Lo L.H., Chen Y.H., et al. Study of human neutrophil peptides in saliva by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2009, 23:3220-3226.
68. Chen Y.C., Li T.Y., Tsai M.F. Analysis of the saliva from patients with oral cancer by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2002, 16:364-369.
69. Hsu W.Y., Lo W.Y., Lai C.C., et al. Rapid screening assay of trimethylaminuria in urine with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2007, 21:1915-1919.
70. Chiang Y.Y., Cho Y.T., Shiea J. The study of breast cancer tissues by imaging mass spectrometry. Taiwan Society for Mass Spectrometry Annual Conference, 8th, Kaouhsing, Taiwan 2011.
71. Sakai K., Okuyama H., Yura J., et al. Composition and turnover of phospholipids and neutral lipids in human breast cancer and reference tissues. Carcinogenesis 1992, 13:579-584.
72. Glunde K., Jacobs M.A., Pathak A.P., Artemov D., Bhujwalla Z.M. Molecular and functional imaging of breast cancer. NMR Biomed 2009, 22:92-103.
73. Fernandis A.Z., Wenk M.R. Lipid-based biomarkers for cancer. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:2830-2835.
74. Wang H., Manicke N.E., Yang Q., et al. Direct analysis of biological tissue by paper spray mass spectrometry. Anal Chem 2011, 83:1197-1201.
75. Nimmagadda S., Glunde K., Pomper M.G., Bhujwalla Z.M. Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells. Neoplasia 2009, 11:477-484.
76. Jollifee I.T. Principal components analysis 2002, 487. Springer.
77. Djidja M.C., Claude E., Snel M.F., et al. Novel molecular tumour classification using MALDI-mass spectrometry imaging of tissue micro-array. Anal Bioanal Chem 2010, 397:587-601.
78. Ward J.H. Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963, 58:236-244.
79. Sidransky D., Irizarry R., Califano J.A., et al. Serum protein MALDI profiling to distinguish upper aerodigestive tract cancer patients from control subjects. J Natl Cancer Inst 2003, 95:1711-1717.
80. Seraglia R., Ragazzi E., Vogliardi S., et al. Search of plasma markers for colorectal cancer by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom 2005, 40:123-126.
81. Ragazzi E., Pucciarelli S., Seraglia R., et al. Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer. J Mass Spectrom 2006, 41:1546-1553.
82. Lapolla A., Fedele D., Traldi P. Glyco-oxidation in diabetes and related diseases. Clin Chim Acta 2005, 357:236-250.
83. Ragazzi E., Vogliardi S., Allegri G., et al. Cluster analysis of serum proteins in malignant cutaneous melanoma: search for disease markers. Rapid Commun Mass Spectrom 2003, 17:1511-1515.
84. Ferrari L., Seraglia R., Rossi C.R., et al. Protein profiles in sera of patients with malignant cutaneous melanoma. Rapid Commun Mass Spectrom 2000, 14:1149-1154.
85. Lapolla A., Seraglia R., Molin L., et al. Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study. J Mass Spectrom 2009, 44:419-425.
86. Lapolla A., Molin L., Sechi A., et al. A further investigation on a MALDI-based method for evaluation of markers of renal damage. J Mass Spectrom 2009, 44:1754-1760.
87. Lapolla A., Molin L., Seraglia R., et al. Urinary peptides as a diagnostic tool for renal failure detected by matrix-assisted laser desorption/ionisation mass spectrometry: an evaluation of their clinical significance. Eur J Mass Spectrom (Chichester, Eng) 2011, 17:245-253.
88. Zerefos P., Prados J., Kossida S., Kalousis A., Vlahou A. Sample preparation and bioinformatics in MALDI profiling of urinary proteins. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 853:20-30.
89. Calvano C.D., Aresta A., Iacovone M., et al. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles. J Pharm Biomed Anal 2010, 51:907-914.
90. Koomen J.M., Zhao H., Li D., Abbruzzese J., Baggerly K., Kobayashi R. Diagnostic protein discovery using proteolytic peptide targeting and identification. Rapid Commun Mass Spectrom 2004, 18:2537-2548.
91. Dekker L.J., Dalebout J.C., Siccama I., Jenster G., Sillevis Smitt P.A., Luider T.M. A new method to analyze matrix-assisted laser desorption/ionization time-of-flight peptide profiling mass spectra. Rapid Commun Mass Spectrom 2005, 19:865-870.
92. Dekker L.J., Boogerd W., Stockhammer G., et al. MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer. Mol Cell Proteomics 2005, 4:1341-1349.
93. Lo L.H., Huang T.L., Shiea J. Acid hydrolysis followed by matrix-assisted laser desorption/ionization mass spectrometry for the rapid diagnosis of serum protein biomarkers in patients with major depression. Rapid Commun Mass Spectrom 2009, 23:589-598.